Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6 + cells
Infection and Immunity · 2024
DOI: 10.1128/iai.00309-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Immunity, 2024. Verfasst von Louis-Philippe Leroux und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Recherche Scientifique (INRS)-Centre Armand-Frappier Santé Biotechnologie (CAFSB), Laval, Québec, Canada. Hauptthemen laut MEDLINE: Chemokine CXCL16, Toxoplasma, Macrophages, Receptors, CXCR6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
CXCL16 is a multifaceted chemokine expressed by macrophages and other immune cells in response to viral and bacterial pathogens. However, few studies have investigated its role in parasitic infections. The obligate intracellular parasite Toxoplasma gondii ( T. gondii ) is the causative agent of toxoplasmosis, an infection with potentially deleterious consequences in immunocompromised individuals and the developing fetus of acutely infected pregnant women. Chemokines are critical mediators of host defense and, as such, dysregulation of their expression is a subversion strategy often employed by the parasite to ensure its survival. Herein, we report that types I and II T. gondii strains upregulated the expression of both transmembrane and soluble forms of CXCL16 in infected bone marrow-derived macrophages (BMDM). Exposure to soluble T. gondii antigens (STAg) and to excreted–secreted proteins (TgESP) led to the induction of CXCL16. Cxcl16 mRNA abundance and CXCL16 protein levels increased in a time-dependent manner upon T. gondii infection. Importantly, conditioned medium (CM) collected from T. gondii -infected wild-type (WT) macrophage cultures promoted the migration of RAW264.7 cells expressing CXCR6, the cognate receptor of CXCL16, an effect that was significantly reduced by a neutralizing anti-CXCL16 antibody or use of CM from CXCL16 knockout (KO) macrophages. Lastly, T. gondii -driven CXCL16 expression appeared to modulate cytokine-induced (IL-4 + IL-13) alternative macrophage activation and M2 phenotypic marker expression. Further investigation is required to determine whether this chemokine contributes to the pathogenesis of toxoplasmosis and to elucidate the underlying molecular mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut National de la Recherche Scientifique (INRS)-Centre Armand-Frappier Santé Biotechnologie (CAFSB), Laval, Québec, Canada.
- Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
ORCID-Profile: Louis-Philippe Leroux, Visnu Chaparro, Brent Johnston, Maritza Jaramillo
Förderung
- Canadian Government | Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Leroux, L. P., Chaparro, V., Plouffe, A., Johnston, B., & Jaramillo, M. (2024). Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6 + cells. Infection and Immunity. https://doi.org/10.1128/iai.00309-24
Vancouver
Leroux LP, Chaparro V, Plouffe A, Johnston B, Jaramillo M. Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6 + cells. Infection and Immunity. 2024. doi:10.1128/iai.00309-24
BibTeX
@article{Leroux2024,
author = {Leroux, Louis-Philippe and Chaparro, Visnu and Plouffe, Alexandra and Johnston, Brent and Jaramillo, Maritza},
title = {Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6 + cells},
journal = {Infection and Immunity},
year = {2024},
doi = {10.1128/iai.00309-24}
}
EUVIMED